About: Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 29 December 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в грудні 2006 (uk) im Dezember 2006 veröffentlichter wissenschaftlicher Artikel (de) scientific article published on 29 December 2006 (en) artículu científicu espublizáu n'avientu de 2006 (ast)
publication date	wds:Q79717114-4647875E-D615-48C3-9318-FBBE2FBB6E72
publication date	2006-12-29 00:00:00Z (xsd:dateTime)
cites work	wds:Q79717114-33FE7FEB-6DE9-4744-BA2E-96CCFB3BD7CB wds:Q79717114-34ADB03A-DD3F-44D0-A7F9-59763D252065 wds:Q79717114-436E251A-31B8-4FE5-B00B-E1D1F3DD5423 wds:Q79717114-484DF068-9FA5-4B48-9058-AAD79114857F wds:Q79717114-532B48E4-9E23-4F88-AE6D-4A031CFD4A01 wds:Q79717114-53E413FA-C1F0-4B75-B3D9-BBAFCDA1F4BF wds:Q79717114-54F84A1D-2019-4E1C-90C6-D5D1FE73DF75 wds:Q79717114-593EC922-0577-43B8-B13C-823515919457 wds:Q79717114-7694D99D-8979-4B7E-85B7-B625C8F8143D wds:Q79717114-AE223BFB-FBD7-4C8F-A4FB-3967905F11BB wds:Q79717114-D4D52988-AA56-4B70-9848-7037FA259290 wds:Q79717114-E320E5FC-EC84-42D3-A0E2-83D8F16D6D6E wds:Q79717114-F376E754-2B8D-4F8E-8BA7-965740918721
cites work	Incidence of hepatitis B virus infection in the United States, 1976-1994: estimates from the National Health and Nutrition Examination Surveys A controlled clinical trial of the efficacy of the hepatitis B vaccine (Heptavax B): a final report Risks of chronicity following acute hepatitis B virus infection: a review Booster vaccination with recombinant hepatitis B vaccine four years after priming with one single dose The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center efficacy trial among homosexual men A novel hepatitis B vaccination regimen for adolescents: two doses 12 months apart Predictors of time to completion of the hepatitis B vaccination series among adolescents Compliance of hepatitis B vaccination in patients presenting to a teenage clinic A randomized trial of alternative two- and three-dose hepatitis B vaccination regimens in adolescents: antibody responses, safety, and immunologic memory. Chronic hepatitis B Universal hepatitis B immunization: young adolescent immunization Hepatitis B vaccination: how to reach risk groups Economic evaluation of a 2-dose hepatitis B vaccination regimen for adolescents
author name string	wds:Q79717114-28BDB0BD-CB68-454C-88C2-2ED109A79F40 wds:Q79717114-55544C4C-BA31-4B1D-BB7A-4840A8C71C66 wds:Q79717114-82438B71-AA22-4BE1-9615-FE8EBA866A87 wds:Q79717114-9967A790-ECEF-4E97-BD58-84F789A15A4B wds:Q79717114-C18B9EC8-AC58-494C-88A9-A890017253E5 wds:Q79717114-CFF6461F-CEAC-4E26-86F4-FD2B780FE936 wds:Q79717114-D077499E-6AC6-4661-B52E-EB0DA2483428 wds:Q79717114-FA9235DF-EC81-4404-B7B0-92F298B29F29
author name string	Leon Heron Bernard Hoet Pierre Van Damme Michel Stoffel Karin Levie Anna Moiseieva Marie van der Wielen Olga Selnikova
rdfs:label	Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (en) Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (nl)
skos:prefLabel	Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (en) Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (nl)
name	Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (en) Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (nl)
title	wds:Q79717114-B326E9F5-ACCB-48E7-B1BB-5795F21FBEE2
title	Immunogenicity, reactogenicity and safety of two-dose versus three-dose (standard care) hepatitis B immunisation of healthy adolescents aged 11-15 years: a randomised controlled trial (en)
page(s)	wds:Q79717114-94193CC6-37DF-4F42-BE09-A1C5727D74C8
page(s)	2817-2822
instance of	wds:Q79717114-C245BBEB-AB89-46A5-A8C1-E24319AF9711
instance of	scholarly article
main subject	wds:Q79717114-86342015-B6D5-4453-B35C-89E059FEAE79
main subject	hepatitis B
PubMed ID	wds:Q79717114-C474484F-B929-4A89-8041-95865D196611
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17276552
PubMed ID	17276552
published in	wds:Q79717114-F2CB4676-1297-4493-87D6-4DCC2DFA6370
published in	Vaccine
issue	wds:Q79717114-D486C347-9BCC-4BF4-A475-83B0137EA4EA
volume	wds:Q79717114-D7537A99-2352-407D-B395-AB09CEAFC25E
issue	15
volume	25
DOI	wds:Q79717114-90B09730-4FC2-4B35-B5D5-3338965DB224
DOI	http://dx.doi.org/10.1016/J.VACCINE.2006.12.021
DOI	10.1016/J.VACCINE.2006.12.021
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79717114
is cites work of	Scaling up human papillomavirus vaccination: a conceptual framework of vaccine adherence Five years follow-up following two or three doses of a hepatitis B vaccine in adolescents aged 11-15 years: a randomised controlled study Long-term anti-HBs antibody persistence following infant vaccination against hepatitis B and evaluation of anamnestic response: a 20-year follow-up study in Thailand Feasibility of completing an accelerated vaccine series for homeless adults Alginate-chitosan-PLGA composite microspheres enabling single-shot hepatitis B vaccination Vaccine-like controlled-release delivery of an immunomodulating peptide to treat experimental autoimmune encephalomyelitis Hepatitis B vaccination strategies tailored to different endemicity levels: some considerations Economic evaluation of infant and adolescent hepatitis B vaccination in the UK Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Persistence and immune memory to hepatitis B vaccine 20 years after primary vaccination of Thai infants, born to HBsAg and HBeAg positive mothers High coverage of hepatitis B vaccination and low prevalence of chronic hepatitis B in migrant children dictate a new catch-up vaccination strategy
is cites work of	wds:Q33776106-69E884EB-B444-43DD-8EDD-96372160655B wds:Q35977996-5AB5D28E-018E-46A1-A723-1BC0D5909DEB wds:Q82442592-0559BB15-06AD-4E56-8848-9AC5EEF738A0 wds:Q47738773-13244B0C-0F85-46E1-8C04-55B0A5ACA273 wds:Q35121855-0B6D05A8-F482-4B16-A563-8884C405F655 wds:Q89119672-A90E0C3C-9221-4864-8109-28216EE33494 wds:Q37637011-41109A02-8E88-4FE9-85E4-4505A3A9F383 wds:Q37191129-6D6E739D-CC58-4CB8-A7C7-916A89AAE443 wds:Q34293716-8009E390-FD96-43FF-9FC1-53711B23266A wds:Q37530077-38981D23-691C-457E-8BEB-6495121216F1 wds:Q36391894-5A999281-9056-4B4A-8E16-FCE203007B57

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software